ReNetX Bio
PrivateLast Round
Series A
Extension
Sep 30, 2020
Total Funding Raised
$1M
Company Overview
ReNetX Bio is a biotechnology company that develops first-in-class therapeutics to treat injuries and damage to the central nervous system, including spinal cord injury, stroke, and glaucoma.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ReNetX Bio Comparables
Compare ReNetX Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| BioAxone BioSciences | 82% | |
| Neuroplast | 82% | |
| NervGen Pharma Corp. | 81% | |
ReNetX Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Sep 30, 2020 | ||||
| Series A | May 8, 2018 | ||||
| Convertible Debt | Jul 10, 2014 | ||||
| Corporate Funding | May 1, 2012 |
ReNetX Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Connecticut Innovations | Convertible Debt, Series A Extension, Series A |
| Wings for Life Foundation | Series A |
| Spring Mountain Capital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 1, 2012
AstraZeneca participated in the round.
ReNetX Bio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about ReNetX Bio's valuation, stock price, and market status.